A regenerative medicine company

Established to transform innovative concepts into cutting edge wound care therapies.

Our patented manufacturing process

Delicately preserves biological materials and produce highly standardised multi-plattform regenerative products that are easy to ship, use and store.

An innovative human amnion-derived regenerative therapy that is ready to use, ‘off the shelf’

Bespoke application

Delivering Omnigen regeneration in the clinic, without the need of surgery.

A complementary tissue service

Providing clinical centres with improved access to Omnigen, whilst avoiding risk of wasting surplus tissue and money.

A regenerative medicine company

Amniotic membrane derived dry matrix (human)

Bespoke contact lens application of Omnigen

Storage to provide Omnigen access when you need it

Creating uniform wound margins for easier application

Developing high quality and affordable wound care regenerative therapies

Latest News

NuVision appoints new chairman – Dr Mark Treherne  

NuVision Biotherapies is delighted to announce the appointment of its new chairman, Dr Mark Treherne. Mark has a PhD in Pharmacology from Cambridge University along with over 25 years of industrial R&D experience in the discovery and development of novel...

NuVision follows its vision with £500,000 investment

NuVision Biotherapies is delighted to announce the recent completion of a £500,000 funding round backed by Mercia Fund Managers, angel investors and the University of Nottingham. The investment will enable the company to increase sales both in the UK and to develop...

NuVision is Recruiting a Sales Team

We are currently inviting applications for opportunities with the Commercial Specialist Team. We have opportunities on the following territories: Southern England London and East Anglia Midlands North England About NuVision Biotherapies This is your chance to join one...

Click to follow

Interested in purchasing?

Register your interest